Evidence map›Paper›PMID 40463577›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Comprehensive investigation of DNA damage repair genes in children with cancer identifies

Ninad Oak, Wenan Chen, Alise Blake, Lynn Harrison, Martha O'Brien, Christopher Previti, Gnanaprakash Balasubramanian, Kendra Maass, Steffen Hirsch, Judith Penkert and 20 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Ninad OakDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-9806-0217
Wenan ChenCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
Alise BlakeDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Lynn HarrisonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Martha O'BrienHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Christopher PrevitiHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Gnanaprakash BalasubramanianHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Kendra MaassHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Steffen HirschHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Judith PenkertPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Barbara C JonesHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Kathrin SchrammHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Michaela NathrathPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Uta DirksenPediatrics III, West German Cancer Center University Hospital Essen, Essen, Germany.ORCID 0000-0002-5435-7860
Jiaming LiDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Yadav SapkotaDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Kirsten K NessDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Lillian M GuentherDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Christian KratzPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Zhaoming WangDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Greg T ArmstrongDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Melissa M HudsonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-6984-2407
Gang WuCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-1678-5864
Robert J AutryHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Kim E NicholsDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-5581-6555
Richa SharmaDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Mach-LETSGO: Machine-LEarning of Treatment, Survey, and Genetics towards Obtaining Correct Classification of Chronic Conditions in Adult Survivors in the Childhood Cancer Survivor Study - CCSS SupplU24CA055727 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Gregory Armstrong · 1999 to 2026
$96.7M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
Genetic pleiotropy across pediatric cancers, and cancer-related outcomesR01CA283333 · NCI · UNIVERSITY OF MINNESOTA · PI Cindy Im · 2024 to 2026
$2.2M
NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA283333NCI NIH HHS U01 CA195547NCI NIH HHS U24 CA055727
6 · The paper itself

Abstract

Background: Recent large-scale genomic sequencing studies reveal that 5-18% of children with cancer harbor pathogenic variants (PV) in known cancer predisposing genes (CPG). However, DNA damage repair (DDR) genes, which are frequently somatically altered in pediatric tumors, have not been systematically examined as a source of novel cancer predisposing signals. Methods: To address this gap, we interrogated 189 genes across six DDR pathways for the presence of PV among 5,993 childhood cancer cases and 14,477 adult non-cancer controls. PV were defined as rare (allele frequency <0.05% in the gnomAD v2.1 non-cancer subset), nonsense, frameshift, affecting canonical splice sites, and missense with REVEL score >0.7. Using logistic and firth regression, we identified genes with statistically enriched PV and replicated findings among 1,494 additional childhood cancer cases across three independent cohorts. Findings: Analysis across all cancers revealed enrichment of Interpretation: Our study identifies

Identifiers

PMID40463577
PMCPMC12132114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.